| Serial Number | 86364754 |
| Word Mark | SOCTEC |
| Filing Date | Tuesday, August 12, 2014 |
| Status | 705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED |
| Status Date | Wednesday, January 22, 2025 |
| Registration Number | 5494819 |
| Registration Date | Tuesday, June 19, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 3, 2018 |
| Goods and Services | [ Pharmaceuticals having a self-orienting effect, namely, orally delivered pharmaceuticals with modified time release into the gastrointestinal system; gastro retentive pharmaceuticals; self orienting pharmaceuticals in the form of capsules, namely, capsules consisting of segments of varied functions and absorption rates, resulting in controlled release into the gastrointestinal tract; Gastrointestinal drug delivery preparations for medical, surgical and biological purposes; chronotherapy-focused tablets, analgesics; Medicines for treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; medicinal preparations for treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; capsules for the release of colonic drug delivery; pharmaceuticals for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders, medical and veterinary preparations for body slimming purposes; capsules, suppositories, tablets and pills for pharmaceutical, medical and veterinary purposes for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pre-filled vials containing medical diagnostic reagents; exclude goods being related to the treatment of respiratory diseases ] |
| Translation of Words in Mark | The word(s) "SOCTEC" has no meaning in a foreign language. |
| Goods and Services | [ Medical services; veterinary services; hygienic care for human beings or animals; medical analysis for the diagnosis and treatment of persons treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pharmacy advice; provision of information relating to medical, surgical and veterinary matters online from a computer database or over the Internet; exclude services in the field of inhalation technology ] |
| Goods and Services | [ inhalers for medical purposes; injection apparatus, instruments and devices, namely, medical apparatus in the nature of an infusion injection device for administering drugs; apparatus, instruments and devices, namely, automated drug delivery systems for storing and dispensing medical, surgical and veterinary preparations, capsules, powders, tablets and pills; instruments and apparatus for the administration of self-orientation therapy and prophylaxis preparations and substances, namely, gastrointestinal drug delivery systems, syringes and fluid injectors for medical purposes; exclude goods being related to the treatment of respiratory diseases ] |
| Goods and Services | Scientific and technological services, namely, custom design exclusively in the pharmaceuticals and medical fields; design services exclusively in the pharmaceuticals and medical fields; drug development and custom design of pharmaceuticals and medical goods; exclude services in the field of inhalation technology |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 21, 2014 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | B - Sec. 8 - Class(es) in a Multiple Class registration |
| Class Status Date | Wednesday, January 22, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | B - Sec. 8 - Class(es) in a Multiple Class registration |
| Class Status Date | Wednesday, January 22, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | B - Sec. 8 - Class(es) in a Multiple Class registration |
| Class Status Date | Wednesday, January 22, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SKYEPHARMA PRODUCTION S.A.S. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | SAINT-QUENTIN-FALLAVIER FR |
| Party Name | Jagotec AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | 4132 Muttenz CH |
| Party Name | Jagotec AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | 4132 Muttenz CH |
| Party Name | Jagotec AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | 4132 Muttenz CH |
| Event Date | Event Description |
| Wednesday, November 26, 2014 | NON-FINAL ACTION WRITTEN |
| Friday, August 15, 2014 | NEW APPLICATION ENTERED |
| Thursday, August 21, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 25, 2014 | ASSIGNED TO EXAMINER |
| Wednesday, November 26, 2014 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 26, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 26, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, June 1, 2015 | ASSIGNED TO LIE |
| Monday, June 8, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 8, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 25, 2015 | SUSPENSION LETTER WRITTEN |
| Thursday, June 25, 2015 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, June 25, 2015 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, December 29, 2015 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Wednesday, January 20, 2016 | SUSPENSION LETTER WRITTEN |
| Wednesday, January 20, 2016 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, January 20, 2016 | LETTER OF SUSPENSION E-MAILED |
| Thursday, July 14, 2016 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, July 14, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 15, 2016 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Thursday, July 14, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 20, 2016 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Monday, August 15, 2016 | PRIORITY ACTION WRITTEN |
| Monday, August 15, 2016 | PRIORITY ACTION E-MAILED |
| Tuesday, January 31, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, January 31, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 31, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 31, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, January 31, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 7, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, February 22, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 14, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 14, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 9, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 31, 2017 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, October 31, 2017 | NOTICE OF ALLOWANCE CANCELLED |
| Tuesday, October 31, 2017 | CASE RETURNED TO EXAMINATION |
| Thursday, November 2, 2017 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, October 31, 2017 | SUSPENSION LETTER WRITTEN |
| Tuesday, October 31, 2017 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, October 31, 2017 | LETTER OF SUSPENSION E-MAILED |
| Friday, November 3, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 3, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 27, 2017 | NON-FINAL ACTION WRITTEN |
| Monday, November 27, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 27, 2017 | NON-FINAL ACTION E-MAILED |
| Monday, February 12, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Sunday, April 29, 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, February 12, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Monday, February 12, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 13, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, February 13, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, February 26, 2018 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, March 14, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 3, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 3, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, August 22, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, January 21, 2025 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Wednesday, January 22, 2025 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Wednesday, January 22, 2025 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Tuesday, June 19, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Monday, June 19, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Thursday, August 29, 2024 | TEAS SECTION 8 & 15 RECEIVED |